2013
DOI: 10.1016/s0025-7753(13)70051-4
|View full text |Cite
|
Sign up to set email alerts
|

Análogos de la GnRH en el tratamiento de los miomas

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
1
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 28 publications
0
1
0
Order By: Relevance
“…Therefore, these compounds helped to restore haemoglobin levels and reduce blood loss during surgery. Their main disadvantage was rebound growth of fibroids upon cessation of therapy, along with the side effects associated with hypoestrogenism, such as climacteric symptoms and loss of bone mass [ 8 ]. Selective oestrogen receptor modulators (SERMs), such as raloxifene, were shown to induce fibroid regression only in postmenopausal women, but the therapy had major side effects.…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, these compounds helped to restore haemoglobin levels and reduce blood loss during surgery. Their main disadvantage was rebound growth of fibroids upon cessation of therapy, along with the side effects associated with hypoestrogenism, such as climacteric symptoms and loss of bone mass [ 8 ]. Selective oestrogen receptor modulators (SERMs), such as raloxifene, were shown to induce fibroid regression only in postmenopausal women, but the therapy had major side effects.…”
Section: Introductionmentioning
confidence: 99%
“…En cuanto a los anticonceptivos orales aplicados con antiinflamatorios no esteroideos y progestanos no ha presentado una efectividad contundente frente la presencia de fibromas. 57 Entre estos anticonceptivos se tiene el acetato de medroxiprogesterona de depósito (AMPD, hormona de tipo sintética aplicada intramuscularmente dirigida a reducir el tamaño del fibroma, la levonorgestrel dispositivo intrauterino que actúa liberando progesterona originando la supresión del endometrio por lo tanto reduce el sangrado mestrual. 58 Acetato de Ulipristal.-Son moduladores selectivos de los receptores de progesterona (SPRM), como el acetato de ulipristal, empleados en los tratamientos de miomas con sintomatología de moderada a severa es una buena alternativa no quirúrgica, hallándose contraindicado en pacientes con trastorno hepático, 59 consiste en la toma oral de Analítico debido a que se evaluó la asociación de los factores reproductivos y endocrinos con el desarrollo de fibroma uterino.…”
Section: Antiinflamatorios (Aines)unclassified
“…Factor asociado a los estrógenos y progesterona que influyen, alterando el funcionamiento normal del miometrio del ovario. [42][43][44][45][46][47][48][49][50][51][52][53][54][55][56][57] Perdida espontanea del producto…”
Section: Factores Endocrinosunclassified